Goal: to understand how host niches, epi/genetics, aging, lifestyle & treatments influence residual cancer dormancy to detect, prevent & treat cancer relapse
The CDI announces the launch of the Cancer Dormancy Institute Service Core. The Core provides expert advice on markers, mouse, avian and 3D models, protocol development and rare cell isolation methods to explore this unique cancer biology montefioreeinstein.org/cancer/researc…
An interesting test of measuring host variations as a readout of early existing metastasis. A concept that needs to be further analysis of niche specific biomarkers: link.springer.com/article/10.100…